Peptide and Protein Bioanalysis Boot Camp
Building Proficiency in LC-MS Large Molecule Quantification
Building Proficiency in LC-MS Large Molecule Quantification
Dr. Kelly Doering leads a business team within Waters’ Global Marketing group that focuses on the promotion of mass spectrometry solutions to Discovery and DMPK labs. Prior to Waters, she worked in a variety of commercial roles including product management, business development and new product development. She earned her doctorate from the University of Connecticut, studying nutrient regulation of hepatic gene expression in mice and then completed a post-doctoral fellowship in the Department of Endocrinology at Boston Childrens Hospital, studying the effects of glycemic index on body composition, also in rodent models. Before graduate school, she worked in Nutrition Research within the Division of Preventive & Behaviorial Medicine at UMass Medical Center, where she worked on a number of NIH funded projects, mainly centered around lifestyle interventions to improve cardiovascular outcomes.
XKhalid Khan is a senior manager with Waters Global Marketing, focusing on clinical and biomedical research applications. He has been involved in mass spectrometry technology for over 25 years since his postgraduate research studies where high resolution GC-MS data played a key role in the identification of novel organic compounds. Khalid joined Waters in 2001 and has been involved in both technical and business development roles in clinical diagnostics, toxicology and biomedical research applications of LC-MS. Khalid is currently focused on biomarker translation and quantification, with a particular interest in utilizing LC-MS in combination with advanced informatics to aid protein and peptide quantification to help advance biomedical research and drug development.
XDr. Kelly Doering leads a business team within Waters’ Global Marketing group that focuses on the promotion of mass spectrometry solutions to DMPK/Bioanalysis labs. Prior to Waters, she worked in a variety of commercial roles including product management, business development and new product development. She earned her doctorate from the University of Connecticut, studying nutrient regulation of hepatic gene expression in mice and then completed a post-doctoral fellowship in the Department of Endocrinology at Boston Childrens Hospital, studying the effects of glycemic index on body composition, also in rodent models. Before graduate school, she worked in Nutrition Research within the Division of Preventive & Behaviorial Medicine at UMass Medical Center, where she worked on a number of NIH funded projects, mainly centered around lifestyle interventions to improve cardiovascular outcomes.
XCaitlin received her bachelor’s in Chemistry from Northeastern University (Boston, MA) where she participated in their signature cooperative education program. Leveraging her co-op experiences into a full-time position, Caitlin started her career in the field of proteomics. In this position, she learned that she loved bioanalytical chemistry, especially mass spectrometry. Caitlin joined Waters in 2016 as an Associate Applications Scientist where she provides support for new product development and discovery bioanalysis of proteins and peptides. She is responsible for all aspects of method development, including sample preparation, liquid chromatography, and mass spectrometry. She enjoys working on solutions to challenging bioanalytical applications and sharing her work with customers.
XMary received her B.S. in Chemistry from the Western Connecticut State University and her M.S. in Chemistry from Central Connecticut State University. She began her bioanalytical career in 1997 with a global Pharmaceutical company where she supported research and discovery efforts by performing DMPK studies and conducting various bioanalytical assays until 2011. Mary joined Waters in 2011, providing pharmaceutical applications development and support for the Waters Scientific Operations Group. Mary’s primary role is to support discovery bioanalysis, and develop bioanalytical methods for drug molecules, both large and small. She is responsible for sample preparation, mass spectrometry, and LC method development.
XMary received her B.S. in Chemistry from the Western Connecticut State University and her M.S. in Chemistry from Central Connecticut State University. She began her bioanalytical career in 1997 with a global Pharmaceutical company where she supported research and discovery efforts by performing DMPK studies and conducting various bioanalytical assays until 2011. Mary joined Waters in 2011, providing pharmaceutical applications development and support for the Waters Scientific Operations Group. Mary’s primary role is to support discovery bioanalysis, and develop bioanalytical methods for drug molecules, both large and small. She is responsible for sample preparation, mass spectrometry, and LC method development.
X